Vanguard Group Inc Pacific Biosciences Of California, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 16,379,972 shares of PACB stock, worth $26.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,379,972

Previous 16,017,175 2.27%

Holding current value

$26.4 Million

Previous $19.9 Million 5.56%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$1.17 - $1.69 $424,472 - $613,126	362,797 Added 2.27%	16,379,972 $21 Million
Q2 2025 Aug 11, 2025	SELL	$0.91 - $1.45 $224,122 - $357,119	-246,289 Reduced 1.51%	16,017,175 $19.9 Million
Q1 2025 May 09, 2025	BUY	$1.14 - $2.1 $1.18 Million - $2.18 Million	1,036,606 Added 6.81%	16,263,464 $19.2 Million
Q4 2024 Feb 11, 2025	SELL	$1.55 - $2.65 $3.74 Million - $6.4 Million	-2,415,946 Reduced 13.69%	15,226,858 $27.9 Million
Q3 2024 Nov 13, 2024	SELL	$1.2 - $2.17 $10 Million - $18.1 Million	-8,356,139 Reduced 32.14%	17,642,804 $30 Million
Q2 2024 Aug 13, 2024	SELL	$1.36 - $3.65 $826,257 - $2.22 Million	-607,542 Reduced 2.28%	25,998,943 $35.6 Million
Q1 2024 May 10, 2024	SELL	$3.52 - $9.59 $644,395 - $1.76 Million	-183,067 Reduced 0.68%	26,606,485 $99.8 Million
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $21 Million - $36.4 Million	3,514,792 Added 15.1%	26,789,552 $263 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $1.22 Million - $2.06 Million	147,993 Added 0.64%	23,274,760 $194 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $8.49 Million - $12 Million	851,077 Added 3.82%	23,126,767 $308 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $15.9 Million - $24 Million	1,996,655 Added 9.85%	22,275,690 $258 Million
Q4 2022 Feb 10, 2023	BUY	$5.67 - $11.2 $3.5 Million - $6.91 Million	616,969 Added 3.14%	20,279,035 $166 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $6.21 Million - $13.5 Million	-1,579,252 Reduced 7.43%	19,662,066 $114 Million
Q2 2022 Aug 12, 2022	BUY	$4.02 - $10.43 $5.21 Million - $13.5 Million	1,296,226 Added 6.5%	21,241,318 $93.9 Million
Q1 2022 May 13, 2022	BUY	$8.43 - $20.9 $760,520 - $1.89 Million	90,216 Added 0.45%	19,945,092 $181 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $35.8 Million - $55.9 Million	1,858,227 Added 10.33%	19,854,876 $406 Million
Q3 2021 Nov 12, 2021	SELL	$24.86 - $35.02 $4.98 Million - $7.01 Million	-200,255 Reduced 1.1%	17,996,649 $460 Million
Q2 2021 Aug 13, 2021	BUY	$22.3 - $36.02 $406 Million - $655 Million	18,196,904 New	18,196,904 $636 Million

Others Institutions Holding PACB

# of Institutions

245

Shares Held

190M

Call Options Held

1.27M

Put Options Held

601K

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $362M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Pacific Biosciences Of California, Inc. Transaction History